207 related articles for article (PubMed ID: 3100630)
1. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
Wyler DJ; Beller DI; Sypek JP
J Immunol; 1987 Feb; 138(4):1246-9. PubMed ID: 3100630
[TBL] [Abstract][Full Text] [Related]
2. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
Panosian CB; Sypek JP; Wyler DJ
J Immunol; 1984 Dec; 133(6):3358-65. PubMed ID: 6208278
[TBL] [Abstract][Full Text] [Related]
3. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
Sypek JP; Panosian CB; Wyler DJ
J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
[TBL] [Abstract][Full Text] [Related]
4. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
5. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
Murray HW; Rubin BY; Carriero S; Acosta AM
J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
[TBL] [Abstract][Full Text] [Related]
6. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
[TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
Nelson BJ; Ralph P; Green SJ; Nacy CA
J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
[TBL] [Abstract][Full Text] [Related]
8. Antigen recognition by effector T cells in antileishmanial defense.
Sypek JP; Panosian CB; Wyler DJ
J Infect Dis; 1985 Nov; 152(5):1057-63. PubMed ID: 2413143
[TBL] [Abstract][Full Text] [Related]
9. Th2 lymphocyte clone can activate macrophage antileishmanial defense by a lymphokine-independent mechanism in vitro and can augment parasite attrition in vivo.
Sypek JP; Matzilevich MM; Wyler DJ
Cell Immunol; 1991 Mar; 133(1):178-86. PubMed ID: 1825032
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
Nacy CA; Meltzer MS; Fortier AH
J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
[TBL] [Abstract][Full Text] [Related]
13. T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.
Sypek JP; Wyler DJ
Infect Immun; 1990 May; 58(5):1146-52. PubMed ID: 2323812
[TBL] [Abstract][Full Text] [Related]
14. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
Bogdan C; Stenger S; Röllinghoff M; Solbach W
Eur J Immunol; 1991 Feb; 21(2):327-33. PubMed ID: 1900240
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
16. Studies on intracellular killing of Leishmania major and lysis of host macrophages by immune lymphoid cells in vitro.
Pham TV; Mauël J
Parasite Immunol; 1987 Nov; 9(6):721-36. PubMed ID: 2448731
[TBL] [Abstract][Full Text] [Related]
17. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
Belosevic M; Davis CE; Meltzer MS; Nacy CA
J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes.
Oster CN; Nacy CA
J Immunol; 1984 Mar; 132(3):1494-500. PubMed ID: 6363544
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
Nacy CA
J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
[TBL] [Abstract][Full Text] [Related]
20. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
Murray HW; Gellene RA; Libby DM; Rothermel CD; Rubin BY
J Immunol; 1985 Oct; 135(4):2374-7. PubMed ID: 3928746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]